Latest news
Whitehawk Therapeutics 2Q 2026: Revenue $0 Net loss $16.64M, EPS $(0.20) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:11:01 GMT3350.SG,0P0001N782,0 (3350.SG) latest press releases and corporate news - Yahoo Finance UKYahoo Finance UK · Thu, 06 Aug 2026 20:01:48 GMTWhitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights - PR NewswirePR Newswire · Thu, 06 Aug 2026 12:00:00 GMTAkari Therapeutics CEO highlights WhiteHawk dual-payload ADC strategy - scanx.tradescanx.trade · Tue, 04 Aug 2026 17:28:51 GMTAkari Therapeutics Highlights WhiteHawk Collaboration and Dual-Payload ADC Strategy in CEO Corner Segment - Quiver QuantitativeQuiver Quantitative · Tue, 04 Aug 2026 13:01:00 GMT